PI
-
Facilitators and barriers for implementation of a decentralized hepatitis C care chain for people who use drugs in Dutch addiction care
von den Hoff, D. W., Ellerbroek, H., Drenth, J. P. H., Berden, F. A. C. & Schellekens, A. F. A., 1 Sept 2025, In: Drug and alcohol dependence. 274, 112759.Research output: Contribution to journal › Article* › Academic › peer-review
-
Prognostic Value of the TLM3 Biomarker Panel for Early Fibrosis Development in MASLD Within the General Population
van Son, K. C., de Jong, J. C. B. C., Özsezen, S., Caspers, M. P. M., Augustijn, Q. J. J., Snabel, J., Galenkamp, H., Hamer, H. M., van Dijk, A.-M., van Koppen, A., Mak, A. L., van den Born, B.-J., Nieuwdorp, M., Drenth, J. P. H., Gluud, L. L., Tushuizen, M. E., Hanemaaijer, R., Verschuren, L. & Holleboom, A. G., 1 Jul 2025, In: Liver International. 45, 7, e70169.Research output: Contribution to journal › Article* › Academic › peer-review
-
Reply to: “Revisiting the use of albumin in patients with cirrhosis – trial design matters”
Lantinga, M. A., Tapper, E. B. & Drenth, J. P. H., Jul 2025, In: Journal of hepatology. 83, 1, p. e57-e58Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications